Department of Internal Medicine and Dermatology, Dietetics, University Medical Center Utrecht, Utrecht, the Netherlands.
Department Gastroenterology and Hepatology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584 CX, the Netherlands.
Eur J Intern Med. 2022 Oct;104:80-88. doi: 10.1016/j.ejim.2022.07.002. Epub 2022 Jul 26.
Impaired nutritional status is a risk factor for unfavorable outcome in cirrhosis.
In this prospective cohort study in hepatocellular carcinoma patients referred for tumor-specific therapy, nutritional status was assessed before and 3 months post-treatment using 4 complementary tools: hand-grip strength (HGS), Liver Frailty Index (LFI), Patient-Generated Subjective Global Assessment (PG-SGA) and skeletal muscle index (L3-SMI). Uni- and multivariable analyses were performed using Kaplan Meier curves and Cox's regression analyses with correction for Barcelona Clinic Liver Cancer (BCLC) stage, alpha-fetoprotein and age.
56 patients were evaluated at baseline and 38 patients 3 months post-treatment. Baseline BCLC stage was 0 in 14%, A in 27%, B in 36%, C in 21%, and D in 2%. HGS, LFI, PG-SGA and L3-SMI were impaired in 13%, 95%, 21% and 71% respectively. Of all patients, 52% died after (median, range) 373 (32-962) days. Of the nutritional assessment tools, only HGS was independently associated with complication-free survival (HR 0.304, 95%CI 0.10-0.88: p = 0.028) and, approaching significance, with overall survival (HR 0.323, 95%CI 0.103-1.008: p = 0.052). Tumor-specific therapy was administered in 50 patients (20% radiofrequency / microwave ablation, 4% resection, 74% transarterial radio- or chemoembolization, 2% sorafenib). Three months post-treatment, complete response occurred in 44%, partial response in 20%, stable disease in 20% and progressive disease in 16%. Child-Pugh scores deteriorated and such deterioration was independently associated with reduced overall and complication-free survival.
reduced baseline HGS and deteriorated post-treatment Child-Pugh score are associated with reduced overall and complication-free survival in HCC.
营养状况受损是肝硬化不良预后的危险因素。
在这项针对接受肿瘤特异性治疗的肝细胞癌患者的前瞻性队列研究中,使用 4 种互补工具(握力、肝脏脆弱指数、患者生成的主观整体评估和 L3 骨骼肌指数)在治疗前和治疗后 3 个月评估营养状况。使用 Kaplan-Meier 曲线和 Cox 回归分析进行单变量和多变量分析,并对巴塞罗那临床肝癌(BCLC)分期、甲胎蛋白和年龄进行校正。
56 例患者在基线时进行评估,38 例患者在治疗后 3 个月时进行评估。基线 BCLC 分期为 0 期 14%,A 期 27%,B 期 36%,C 期 21%,D 期 2%。握力、肝脏脆弱指数、患者生成的主观整体评估和 L3 骨骼肌指数受损分别为 13%、95%、21%和 71%。所有患者中,52%的患者在(中位数,范围)373(32-962)天后死亡。在所有营养评估工具中,只有握力与无并发症生存独立相关(HR 0.304,95%CI 0.10-0.88:p=0.028),且接近总体生存(HR 0.323,95%CI 0.103-1.008:p=0.052)。50 例患者接受了肿瘤特异性治疗(20%射频/微波消融、4%切除、74%经动脉放射或化学栓塞、2%索拉非尼)。治疗后 3 个月,完全缓解 44%,部分缓解 20%,稳定疾病 20%,进展性疾病 16%。Child-Pugh 评分恶化,且这种恶化与总体和无并发症生存的降低独立相关。
基线握力降低和治疗后 Child-Pugh 评分恶化与 HCC 患者的总体和无并发症生存降低相关。